Human Advanced Glycosylation End Product-Specific Receptor (AGER) Protein

Este producto es parte de AGE - Advanced Glycation End Product (Receptor)
Human Advanced Glycosylation End Product-Specific Receptor (AGER) Protein
234€ (2 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human Advanced Glycosylation End Product-Specific Receptor (AGER) Protein
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx680020
Tested Applications
SDS-PAGE

Description

Human Advanced Glycosylation End Product-Specific Receptor (AGER) Protein is a recombinant protein produced in Sf9, Baculovirus cells.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
Advanced Glycosylation End Product-Specific Receptor (AGER)
Host
Insect
Origin
Human
Conjugation
Unconjugated
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
2 µg
Size 2
10 µg
Size 3
1 mg
Form
Liquid
Tested Applications
SDS-PAGE
Availability
Shipped within 5-10 working days.
Dry Ice
No
Alias
RAGE,SCARJ1,sRAGE
Background
Protein AGER
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

AGER, also known as RAGE (Receptor for Advanced Glycation End Products), is a transmembrane receptor belonging to the immunoglobulin superfamily that binds to AGEs and other ligands such as S100 proteins, HMGB1, and amyloid-β. AGER is widely expressed, particularly in the endothelium, lungs, brain, and immune cells, and plays a critical role in inflammatory and oxidative stress signaling. Binding of AGEs to AGER activates downstream pathways, including NF-κB, MAPK, and JAK/STAT, leading to the production of pro-inflammatory cytokines and reactive oxygen species. Overexpression or chronic activation of AGER is associated with diseases such as diabetes complications, atherosclerosis, Alzheimer’s disease, and cancer, where it exacerbates inflammation and tissue damage. AGER is a promising therapeutic target for reducing AGE-mediated pathologies and modulating immune and metabolic dysfunction.

Productos relacionados

abx001218

Advanced Glycosylation End Product-Specific Receptor (AGER) Antibody

AGER Antibody is a Rabbit Polyclonal antibody against AGER. The advanced glycosylation end product (AGE) receptor encode…

Ver producto
abx020069

Advanced Glycosylation End Product-Specific Receptor (AGER) Antibody

Advanced Glycosylation End Product-Specific Receptor (AGER) Antibody is a Rabbit Polyclonal antibody for the detection o…

Ver producto
abx032323

Advanced Glycosylation End Product-Specific Receptor (AGER) Antibody

AGER encodes a member of the immunoglobulin superfamily of cell surface molecules. It is a receptor for various molecule…

Ver producto